 |
|
|
2013 Press/Media Releases: OPKO COMPLETES PATIENT RECRUITMENT IN SECOND PHASE 3 TRIAL OF RAYALDY™ OPKO COMPLETES PATIENT RECRUITMENT IN FIRST PHASE 3 TRIAL OF RAYALDY™ OPKO SURPASSES 50% ENROLLMENT IN SECOND PHASE 3 TRIAL OF RAYALDY™ OPKO SURPASSES 50% ENROLLMENT IN FIRST PHASE 3 TRIAL OF RAYALDY™ (CTAP101 CAPSULES) OPKO HEALTH COMPLETES ACQUISITION OF TWO PHASE 3 PRODUCTS OPKO HEALTH TO ACQUIRE PRIVATELY HELD CYTOCHROMA |
© 2023 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use |